Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Hydroxychloroquine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hydroxybenzoates < Hydroxychloroquine < Hydroxymethylglutaryl-CoA Reductase Inhibitors  Facettes :

List of bibliographic references indexed by Hydroxychloroquine

Number of relevant bibliographic references: 94.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000137 (2020) Xin Lyu [République populaire de Chine] ; Lizhong Zeng [République populaire de Chine] ; Hua Zhang [République populaire de Chine] ; Yue Ke [République populaire de Chine] ; Xuan Liu [République populaire de Chine] ; Nannan Zhao [République populaire de Chine] ; Jingyan Yuan [République populaire de Chine] ; Guoan Chen [République populaire de Chine] ; Shuanying Yang [République populaire de Chine]Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation.
000863 (2019) Priyankar Pal [Inde] ; Hriday De [Inde] ; Prabhas Prasun Giri [Inde] ; Nupur Ganguly [Inde] ; Alolika Mandal [Inde]Early Initiation of Steroid-sparing Drugs in Idiopathic Pulmonary Hemosiderosis.
000B10 (2019) Ali A. Asseri [Oman] ; Yi Zeng ; Cori L. DainesAcute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis.
000B45 (2019) Georgios Mitsiakos [Grèce] ; Christos Tsakalidis [Grèce] ; Paraskevi Karagianni [Grèce] ; Dimitra Gialamprinou [Grèce] ; Ilias Chatziioannidis [Grèce] ; Ioannis Papoulidis [Grèce] ; Ioannis Tsanakas [Grèce] ; Vasiliki Soubasi [Grèce]A New ABCA3 Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome
000C05 (2018) Matthew T. Koroscil [États-Unis] ; Craig A. Rohan ; Michael J. Morris ; Joshua N. ScottWong-Type Dermatomyositis Complicated by Interstitial Lung Disease.
000C10 (2018) Andreu Fernández-Codina [Espagne] ; Kyle M. Walker [Canada] ; Janet E. Pope [Canada]Treatment Algorithms for Systemic Sclerosis According to Experts.
000C16 (2018) Yashpal S. Chhonker [États-Unis] ; Richard L. Sleightholm [États-Unis] ; Jing Li [États-Unis] ; David Oupick [États-Unis] ; Daryl J. Murry [États-Unis]Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies.
000C17 (2018) Oded Breuer [Australie] ; André Schultz [Australie]Side effects of medications used to treat childhood interstitial lung disease.
000C32 (2018) Yong Li [République populaire de Chine] ; Fengjun Cao [République populaire de Chine] ; Mingxing Li [République populaire de Chine] ; Pindong Li [République populaire de Chine] ; Yuandong Yu [République populaire de Chine] ; Longchao Xiang [République populaire de Chine] ; Tao Xu [République populaire de Chine] ; Jinhua Lei [République populaire de Chine] ; Yun Yan Tai [République populaire de Chine] ; Jianyong Zhu [République populaire de Chine] ; Bingbing Yang [République populaire de Chine] ; Yingpin Jiang [République populaire de Chine] ; Xiufang Zhang [République populaire de Chine] ; Long Duo [République populaire de Chine] ; Ping Chen [République populaire de Chine] ; Xiongjie Yu [République populaire de Chine]Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
000C38 (2018) Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour]Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.
000C39 (2018) Sheng Yin [République populaire de Chine] ; Chunyu Xia [République populaire de Chine] ; Yashi Wang [République populaire de Chine] ; Dandan Wan [République populaire de Chine] ; Jingdong Rao [République populaire de Chine] ; Xian Tang [République populaire de Chine] ; Jiaojie Wei [République populaire de Chine] ; Xuhui Wang [République populaire de Chine] ; Man Li [République populaire de Chine] ; Zhirong Zhang [République populaire de Chine] ; Ji Liu [République populaire de Chine] ; Qin He [République populaire de Chine]Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.
000C40 (2018) Cécile Rotenberg [France] ; Valérie Besnard [France] ; Pierre-Yves Brillet [France] ; Stéphane Giraudier [France] ; Hilario Nunes [France] ; Dominique Valeyre [France]Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
000C42 (2018) Anthony M. Lamattina [États-Unis] ; Angelo Taveira-Dasilva [États-Unis] ; Hilary J. Goldberg [États-Unis] ; Shefali Bagwe [États-Unis] ; Ye Cui [États-Unis] ; Ivan O. Rosas [États-Unis] ; Joel Moss [États-Unis] ; Elizabeth P. Henske [États-Unis] ; Souheil El-Chemaly [États-Unis]Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis.
000C50 (2018) Ruiru Li [République populaire de Chine] ; Haobo Lin [République populaire de Chine] ; Yujin Ye [République populaire de Chine] ; Youjun Xiao [République populaire de Chine] ; Siqi Xu [République populaire de Chine] ; Jingnan Wang [République populaire de Chine] ; Cuicui Wang [République populaire de Chine] ; Yaoyao Zou [République populaire de Chine] ; Maohua Shi [République populaire de Chine] ; Liuqin Liang [République populaire de Chine] ; Hanshi Xu [République populaire de Chine]Attenuation of antimalarial agent hydroxychloroquine on TNF-α-induced endothelial inflammation.
000C56 (2018) Weihong Shi ; Mingyang Duan [République populaire de Chine] ; Ligang Jie ; Weifeng SunA successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
000C95 (2017) Souheil El-Chemaly [États-Unis] ; Angelo Taveira-Dasilva [États-Unis] ; Hilary J. Goldberg [États-Unis] ; Elizabeth Peters [États-Unis] ; Mary Haughey [États-Unis] ; Don Bienfang [États-Unis] ; Amanda M. Jones [États-Unis] ; Patricia Julien-Williams [États-Unis] ; Ye Cui [États-Unis] ; Julian A. Villalba [États-Unis] ; Shefali Bagwe [États-Unis] ; Rie Maurer [États-Unis] ; Ivan O. Rosas [États-Unis] ; Joel Moss [États-Unis] ; Elizabeth P. Henske [États-Unis]Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.
000D00 (2017) J. Demarchi [Argentine] ; S. Papasidero [Argentine] ; M A Medina [Argentine] ; D. Klajn [Argentine] ; R. Chaparro Del Moral [Argentine] ; O. Rillo [Argentine] ; V. Martiré [Argentine] ; G. Crespo [Argentine] ; A. Secco [Argentine] ; A. Catalan Pellet [Argentine] ; C. Amitrano [Argentine] ; C. Crow [Argentine] ; C. Asnal [Argentine] ; P. Pucci [Argentine] ; F. Caeiro [Argentine] ; N. Benzanquen [Argentine] ; J P Pirola [Argentine] ; M. Mayer [Argentine] ; F. Zazzetti [Argentine] ; S. Velez [Argentine] ; J. Barreira [Argentine] ; N. Tamborenea [Argentine] ; L. Santiago [Argentine] ; L. Raiti [Argentine]Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
000D15 (2017) Emmanouil Angelakis [France] ; Jacques Bou Khalil [France] ; Marion Le Bideau [France] ; Celine Perreal [France] ; Bernard La Scola [France] ; Didier Raoult [France]Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
000D16 (2017) Otto Hartman [Finlande] ; Petri T. Kovanen [Finlande] ; Jukka Lehtonen [Finlande] ; Kari K. Eklund [Finlande] ; Juha Sinisalo [Finlande]Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.
000D23 (2017) Li Liu [République populaire de Chine] ; Jun Ren [République populaire de Chine] ; Zhiyao He [République populaire de Chine] ; Ke Men [République populaire de Chine] ; Ye Mao [République populaire de Chine] ; Tinghong Ye [République populaire de Chine] ; Hua Chen [République populaire de Chine] ; Ling Li [République populaire de Chine] ; Bocheng Xu [République populaire de Chine] ; Yuquan Wei [République populaire de Chine] ; Xiawei Wei [République populaire de Chine]Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis.
000D49 (2016) Wen Cai Zhang [Singapour] ; Tan Min Chin [Singapour] ; Henry Yang [Singapour] ; Min En Nga [Singapour] ; Declan Patrick Lunny [Singapour] ; Edwin Kok Hao Lim [Singapour] ; Li Li Sun [Singapour] ; Yin Huei Pang [Singapour] ; Yi Ning Leow [Singapour] ; Shanneen Rossellini Y. Malusay [Singapour] ; Priscilla Xin Hui Lim [Singapour] ; Jeravan Zili Lee [Singapour] ; Benedict Jian Wei Tan [Singapour] ; Ng Shyh-Chang [Singapour] ; Elaine Hsuen Lim [Singapour] ; Wan Teck Lim [Singapour] ; Daniel Shao Weng Tan [Singapour] ; Eng Huat Tan [Singapour] ; Bee Choo Tai [Singapour] ; Ross Andrew Soo [Singapour] ; Wai Leong Tam [Singapour] ; Bing Lim [Singapour]Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
000D58 (2016) Joe F. Lau [États-Unis] ; Steven M. Dean [États-Unis] ; Thom W. Rooke [États-Unis] ; Jeffrey W. Olin [États-Unis]Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
000E65 (2015) Águeda Prior-Espa Ol [Espagne] ; Melania Martínez-Morillo [Espagne] ; Anne Riveros-Frutos [Espagne] ; Alejandro Olivé [Espagne][Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
000E66 (2015) Raquel Català Pérez [Espagne] ; Antoni Az N Masoliver [Espagne] ; Salvador Hernández Flix [Espagne][Interstitial lung disease induced by hydroxychloroquine].
000E74 (2015) Loh-Shan B. Leung [États-Unis] ; Joel W. Neal [États-Unis] ; Heather A. Wakelee [États-Unis] ; Lecia V. Sequist [États-Unis] ; Michael F. Marmor [États-Unis]Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
000E92 (2015) Liangkun You [République populaire de Chine] ; Jiawei Shou [République populaire de Chine] ; Danchen Deng [République populaire de Chine] ; Liming Jiang [République populaire de Chine] ; Zhao Jing [République populaire de Chine] ; Junlin Yao [République populaire de Chine] ; Hongsen Li [République populaire de Chine] ; Jiansheng Xie [République populaire de Chine] ; Zhanggui Wang [République populaire de Chine] ; Qin Pan [République populaire de Chine] ; Hongming Pan [République populaire de Chine] ; Wendong Huang [États-Unis] ; Weidong Han [République populaire de Chine]Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines.
000E96 (2015) Ana Freitas [Portugal] ; Virgílio Senra [Portugal] ; Ant Nio Marinho [Portugal] ; Margarida Guedes [Portugal]Chronic alveolar haemorrhage in a paediatric patient: a diagnostic and treatment challenge.
000F01 (2015) Yushu Ruan [République populaire de Chine] ; Ke Hu [République populaire de Chine] ; Hongbo Chen [République populaire de Chine]Autophagy inhibition enhances isorhamnetin‑induced mitochondria‑dependent apoptosis in non‑small cell lung cancer cells.
000F04 (2015) Ralph Yachoui [États-Unis] ; Rahul Sehgal [États-Unis] ; Barkha Amlani [États-Unis] ; Jerry W. Goldberg [États-Unis]Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
000F05 (2015) Kwan-Hwa Chi [Taïwan] ; Hui-Ling Ko [Taïwan] ; Kai-Lin Yang [Taïwan] ; Cheng-Yen Lee [Taïwan] ; Mau-Shin Chi [Taïwan] ; Shang-Jyh Kao [Taïwan]Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.
000F54 (2015) Sarah Braun [Allemagne] ; Marion Ferner [Allemagne] ; Kai Kronfeld [Allemagne] ; Matthias Griese [Allemagne]Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
000F73 (2015) Neil J. Hime [Australie] ; Yvonne Zurynski [Australie] ; Dominic Fitzgerald [Australie] ; Hiran Selvadurai [Australie] ; Amy Phu [Australie] ; Marie Deverell [Australie] ; Elizabeth J. Elliott [Australie] ; Adam Jaffe [Australie]Childhood interstitial lung disease: A systematic review
001005 (2014) Sonia Hammami [Tunisie] ; Fethia Bdioui [Tunisie] ; Afef Ouaz [Tunisie] ; Hichem Loghmari [Tunisie] ; Sylvia Mahjoub [Tunisie] ; Hamouda Saffar [Tunisie]Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus.
001013 (2014) J. Winter [Allemagne] ; S. Essmann [Allemagne] ; A. Kidszun [Allemagne] ; C. Aslanidis [Allemagne] ; M. Griese [Allemagne] ; K. Poplawska [Allemagne] ; M. Bartsch [Allemagne] ; G. Schmitz [Allemagne] ; E. Mildenberger [Allemagne]Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options.
001019 (2014) Annan Yang [États-Unis] ; Alec C. Kimmelman [États-Unis]Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status.
001035 (2014) Janice Santiago O'Farrill [États-Unis] ; Nancy GordonAutophagy in osteosarcoma.
001048 (2014) Michael Williamson [Royaume-Uni] ; Colin Wallis [Royaume-Uni]Ten‐year follow up of hydroxychloroquine treatment for ABCA3 deficiency
001050 (2014) Zeynep Ar Kan-Ayy Ld Z [Turquie] ; Sule Caglayan-Sozmen [Turquie] ; Sakine Is K [Turquie] ; Robin Deterding ; Megan K. Dishop ; Remy Couderc [France] ; Ralph Epaud [France] ; Malek Louha [France] ; Nevin Uzuner [Turquie]Survival of an infant with homozygous surfactant protein C (SFTPC) mutation
001059 (2014) Avraham Avital [Israël] ; Avigdor Hevroni [Israël] ; Simon Godfrey [Israël] ; Shlomo Cohen [Israël] ; Channa Maayan [Israël] ; Samir Nusair [Israël] ; Lawrence M. Nogee [États-Unis] ; Chaim Springer [Israël]Natural history of five children with surfactant protein C mutations and interstitial lung disease
001072 (2014) Mariam Ischander ; Leland L. Fan ; Vanda Farahmand [États-Unis] ; Claire Langston [États-Unis] ; Shahram Yazdani [États-Unis]Desquamative interstitial pneumonia in a child related to cigarette smoke
001104 (2013) Eun Lee [Corée du Sud] ; Ju-Hee Seo ; Hyung Young Kim ; Jinho Yu ; Won-Kyoung Jhang ; Seong-Jong Park ; Ji-Won Kwon ; Byoung-Ju Kim ; Kyung-Hyun Do ; Young Ah Cho ; Sun-A Kim ; Se Jin Jang ; Soo-Jong HongToxic inhalational injury-associated interstitial lung disease in children.
001107 (2013) N. Hepping [Allemagne] ; M. Griese ; P. Lohse ; W. Garbe ; L. LangeSuccessful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine.
001110 (2013) Karina Vilá-Rivera ; Esther Jiménez-Encarnaci N [Porto Rico] ; Salvador ViláPulmonary hemorrhage in a patient initially presenting with discoid lupus.
001131 (2013) Eya Cherif [Tunisie] ; Lamia Ben Hassine [Tunisie] ; Ines Kechaou [Tunisie] ; Narjess Khalfallah [Tunisie]Phalangeal lytic lesion: do not forget osseous sarcoidosis
001160 (2013) Holger Meinicke [Allemagne] ; Andrea Heinzmann [Allemagne] ; Julia Geiger [Allemagne] ; Reinhard Berner [Allemagne] ; Markus Hufnagel [Allemagne]Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12‐year‐old girl
001205 (2013) Hiroshi Kitazawa [Japon] ; Kunihiko Moriya [Japon] ; Hidetaka Niizuma [Japon] ; Kengo Kawano [Japon] ; Yuka Saito-Nanjo [Japon] ; Toru Uchiyama [Japon] ; Takeshi Rikiishi [Japon] ; Yoji Sasahara [Japon] ; Osamu Sakamoto [Japon] ; Yasuhiro Setoguchi [Japon] ; Shigeo Kure [Japon]Interstitial lung disease in two brothers with novel compound heterozygous ABCA 3 mutations
001244 (2013) Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu [Turquie] ; Emre Bozkirli [Turquie] ; Eftal Yucel [Turquie]Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis
001296 (2012) Ralf Zarbock [Allemagne] ; Markus Woischnik ; Christiane Sparr ; Tobias Thurm ; Sun Ana Kern ; Eva Kaltenborn ; Andreas Hector ; Dominik Hartl ; Gerhard Liebisch ; Gerd Schmitz ; Matthias GrieseThe surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
001302 (2012) Ling-Zhi Wang [Singapour] ; Rina Yue-Ling Ong ; Tan-Min Chin ; Win-Lwin Thuya ; Seow-Ching Wan ; Andrea Li-Ann Wong ; Sui-Yung Chan ; Paul C. Ho ; Boon-Cher GohMethod development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry.
001305 (2012) A. Aceti [Italie] ; R. Sciutti ; P R Bracci ; L. Bertelli ; F. Melchionda ; S. CazzatoIdiopathic pulmonary haemosiderosis in a child with Down's syndrome: case report and review of the literature.
001309 (2012) Don Hayes ; Eric A. Lloyd ; Jill A. Fitch ; Andrew BushABCA3 transporter deficiency.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Hydroxychloroquine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Hydroxychloroquine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Hydroxychloroquine
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021